Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
---|---|---|---|---|---|
6530 Q-TOF/C18 NEGATIVE ION MODE | CREATINE (M-H)- | 4756 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | CREATINE (M-H)- | 7331 | Peak area | MCN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | CREATINE (M-H)- | 7714 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | CREATINE (M-H)- | 11617 | Peak area | SCA | N/A |
6530 Q-TOF/C18 NEGATIVE ION MODE | CREATINE (M-H)- | 25249 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 NEGATIVE ION MODE | CREATINE (M-H)- | Peak area | IPMN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | CREATINE (M-H)- | Peak area | MCN | LGD | |
6530 Q-TOF/C18 NEGATIVE ION MODE | CREATINE (M-H)- | Peak area | SCA | N/A | |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | 14939 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | 26905 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | 39391 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | 84397 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | 91135 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | 102038 | Peak area | MCN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | 183334 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | 266371 | Peak area | SCA | N/A |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | 269392 | Peak area | IPMN | LGD |
6530 Q-TOF/C18 POSITIVE ION MODE | CREATINE (M+H)+ | Peak area | IPMN | LGD |